|
|
Article: Pharmaceutical companies establish consortium to secure drug supply chain.(Supply Chain Safety)
- Article from:
- Validation Times
- Article date:
- January 1, 2009
- Author:
CopyrightCOPYRIGHT 2009 Washington Information Source, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
BALTIMORE, MD -- The newest initiative to secure the pharmaceutical supply chain doesn't stem from Congress or FDA. In fact, it's the brainchild of Martin Van Trieste, Amgen's vice president of quality for commercial operations. At the 2009 International Forum Process Analytical Technology (IFPAC) meeting Jan. 25-28, Van Trieste explained why current efforts to protect the safety and integrity of drug products aren't enough.
"There have been recent examples of how the criminal element has crept into our supply chain," he told a plenary session Jan. 26. Referring to the heparin and glycerin incidents responsible for nearly 300 deaths worldwide, Van Trieste ...